{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T06:30:57Z","timestamp":1711780257769},"reference-count":14,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2023]]},"DOI":"10.3960\/jslrt.23016","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T22:15:17Z","timestamp":1690496117000},"page":"177-180","source":"Crossref","is-referenced-by-count":2,"title":["A case of classic Hodgkin lymphoma arising after remission of                    methotrexate-associated follicular lymphoma"],"prefix":"10.3960","volume":"63","author":[{"given":"Yayoi","family":"Ueda","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Okayama Rosai Hospital,                            Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Okayama University Graduate School of                            Medicine, Dentistry and Pharmaceutical Sciences, Okayama,                            Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Asakura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Okayama Rosai Hospital,                            Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomofumi","family":"Yano","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Okayama Rosai Hospital,                            Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Tokuhira                            M,                                Tamaru                            J,                                Kizaki                            M. Clinical                    management for other iatrogenic immunodeficiency-associated lymphoproliferative                    disorders. J Clin Exp Hematop. 2019; 59: 72-92.","DOI":"10.3960\/jslrt.19007"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Tokuhira                            M,                                Tabayashi                            T,                                Tanaka                            Y                    <i>et al.<\/i> The aggressive clinical courses of Hodgkin lymphoma                    primarily diagnosed as methotrexate-induced non-specific lymphoproliferative                    disorder in patients with rheumatoid arthritis. J Clin Exp Hematop. 2017; 56:                    165-169.","DOI":"10.3960\/jslrt.56.165"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Gion                            Y,                                Iwaki                            N,                                Takata                            K                    <i>et al.<\/i> Clinicopathological analysis of methotrexate-associated                    lymphoproliferative disorders: comparison of diffuse large B-cell lymphoma and                    classical Hodgkin lymphoma types. Cancer Sci. 2017; 108:                    1271-1280.","DOI":"10.1111\/cas.13249"},{"key":"4","unstructured":"4 Moseley                            AC,                                Lindsley                            HB,                                Skikne                            BS,                                Tawfik                            O. Reversible                    methotrexate associated lymphoproliferative disease evolving into Hodgkin\u2019s                    disease. J Rheumatol. 2000; 27: 810-813."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 LeBrun                            DP,                                Ngan                            BY,                                Weiss                            LM                    <i>et al.<\/i> The bcl-2 oncogene in Hodgkin\u2019s disease arising in the                    setting of follicular non-Hodgkin\u2019s lymphoma. Blood. 1994; 83:                    223-230.","DOI":"10.1182\/blood.V83.1.223.223"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Momose                            S,                                Tamaru                            J. Iatrogenic                    immunodeficiency-associated lymphoproliferative disorders of B-cell type that                    develop in patients receiving immunosuppressive drugs other than in the                    post-transplant setting. J Clin Exp Hematop. 2019; 59: 48-55.","DOI":"10.3960\/jslrt.19014"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Nam                            MH,                                Hsieh                            YY,                                Chen                            BJ. EBV-positive                    low-grade follicular lymphoma transforming to EBV-negative high-grade B-cell                    lymphoma with MYC and BCL2 rearrangements. Pathology. 2022; 54:                    634-636.","DOI":"10.1016\/j.pathol.2021.09.009"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Mackrides                            N,                                Campuzano-Zuluaga                            G,                                Maque-Acosta                            Y                    <i>et al.<\/i> Epstein-Barr virus-positive follicular lymphoma. Mod                    Pathol. 2017; 30: 519-529.","DOI":"10.1038\/modpathol.2016.214"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Ichikawa                            S,                                Fukuhara                            N,                                Saito                            K                    <i>et al.<\/i> Successful treatment of methotrexate-associated                    classical Hodgkin lymphoma with brentuximab vedotin-combined chemotherapy: a                    case series. Int J Hematol. 2020; 111: 667-672.","DOI":"10.1007\/s12185-020-02822-z"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Kurita                            D,                                Miyoshi                            H,                                Ichikawa                            A                    <i>et al.<\/i> Methotrexate-associated Lymphoproliferative Disorders in                    Patients With Rheumatoid Arthritis: Clinicopathologic Features and Prognostic                    Factors. Am J Surg Pathol. 2019; 43: 869-884.","DOI":"10.1097\/PAS.0000000000001271"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Tsukamoto                            M,                                Morimoto                            T,                                Hirata                            H,                                Yoshihara                            T,                                Mawatari                            M.                    Methotrexate-Associated Lymphoproliferative Disease of the Thoracic Spine                    Misdiagnosed as Metastatic Spinal Tumor: A Case Report. Cureus. 2022; 14:                        e27692.","DOI":"10.7759\/cureus.27692"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Gion                            Y,                                Doi                            M,                                Nishimura                            Y                    <i>et al.<\/i> PD\u2010L1 expression is associated with the spontaneous                    regression of patients with methotrexate\u2010associated lymphoproliferative                    disorders. Cancer Med. 2022; 11: 417-432.","DOI":"10.1002\/cam4.4462"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Sekiguchi                            Y,                                Iizuka                            H,                                Takizawa                            H                    <i>et al.<\/i> Methotrexate-associated Hodgkin Lymphoma in a Patient                    with Rheumatoid Arthritis Successfully Treated with Brentuximab Vedotin in                    Combination with Doxorubicin, Vinblastine, and Dacarbazine (BV+AVD). Intern Med.                    2020; 59: 2165-2171.","DOI":"10.2169\/internalmedicine.4417-20"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Tokuhira                            M,                                Tanaka                            Y,                                Takahashi                            Y                    <i>et al.<\/i> The clinical impact of absolute lymphocyte count in                    peripheral blood among patients with methotrexate - associated                    lymphoproliferative disorders. J Clin Exp Hematop. 2020; 60:                    41-50.","DOI":"10.3960\/jslrt.19039"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/63\/3\/63_23016\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T05:06:25Z","timestamp":1696050385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/63\/3\/63_23016\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.23016","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"23016"}}